Easy-to-Read Informed Consent Forms for Hematopoietic Cell Transplant Clinical Trials. Biol Blood Marrow Transplant, 18, 183-189. presented at the 02/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21806948. (2012).
Grade III - IV Acute GvHD and Treatment-Related Mortality Are Reduced Among Recipients of Larger Numbers of Donor Naïve CD8+ T-cells and Plasmacytoid Dendritic Cell Precursors in Allogeneic BM Grafts from Unrelated Donors: Results from BMT CTN 0201. In 38th Annual EBMT (European Group for Blood and Marrow Transplantation). presented at the 01/04/2012, Geneva, Switzerland. Retrieved from http://www.congrex.ch/ebmt2012.html. (2012).
Informed Consent: Improving the Form and the Process. In PRIM&R: Public Responsibility in Medicine and Research. presented at the 01/12/2011, National Harbor, MD. Retrieved from http://www.primr.org/Conferences.aspx?id=11065. (2011).
Developing Materials for Transplant Centers to Share BMT CTN Clinical Trial Results with their Patients: A Pilot Study (Poster). In NCI ASCO Cancer Trials Accrual Symposium. presented at the 2010, Bethesda, MD. Retrieved from http://university.asco.org/CT2010. (2010).
Maximizing Accrual to Transplant Trials in Multiple Myeloma (MM): Lessons from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), Eastern Cooperative Oncology Group (ECOG) and Cancer and Leukemia Group B (CALGB) Collaboration (Poster). In NCI ASCO Cancer Trials Accrual Symposium. presented at the 2010, Bethesda, MD.. (2010).